ABSTRACT: Objective: This study investigates the relationship between anxiety symptoms and adaptive function in children with chromosome 22q11.2 deletion syndrome (22q11.2DS). Methods: Seventy-eight children between 7 and 14 years of age with 22q11.2DS and 36 typically developing (TD) children without known genetic syndromes participated in a larger study of neurocognition. Parents completed questionnaires about their child's anxiety symptoms (Behavior Assessment System for Children, 2nd edition [BASC-2] and Spence Children's Anxiety Scale [SCAS] ) and adaptive functioning (BASC-2 and Adaptive Behavior Assessment System, 2nd edition). Within the 22q11.2DS group, different DSM-IV anxiety domains were also analyzed using SCAS subscales. Results: Based on parent report, 19% of children with 22q11.2DS had a prior diagnosis of an anxiety disorder versus 58% with at least 1 elevated anxiety score (BASC-2 or SCAS). Mean BASC-2 anxiety scores were significantly higher in 22q11.2DS (55.6 6 12.5) than in TD children (48.3 6 10; p 5 .003), and a greater percentage of children with 22q11.2DS (37%) had an elevated BASC-2 anxiety scores compared with TD children (14%; p 5 .01). Higher anxiety scores were related to lower adaptive function (r 5 2.27; p 5 .015), but there was no relationship between Wechsler Intelligence Scale for Children, 4th edition Full Scale Intelligence Quotient and BASC-2 adaptive skills (r 5 2.06; p 5 .6) in the 22q11.2DS group. For the individual SCAS anxiety subscales, panic-agoraphobia (r 5 2.38; p 5 .03), physical injury (r 5 2.34; p 5 .05), and obsessive-compulsive disorder (r 5 2.47; p 5 .005) were significantly negatively related to adaptive function in 22q11.2DS. Conclusion: Despite the known risk, anxiety is underidentified in children with 22q11.2DS. The presence of anxiety symptoms, but not intelligence levels, in children with 22q11.2DS negatively correlated with adaptive function and impacts everyday living skills. The most common human microdeletion occurs at chromosome 22q11.2 with a prevalence of at least 1:4000 live births. 1 The resulting syndrome is commonly now referred to as chromosome 22q11.2 deletion syndrome (22q11.2DS), encompassing DiGeorge, velocardiofacial, and other syndrome labels. There is a wide spectrum of involvement, and children with 22q11.2DS face multiple challenges from comorbid medical, developmental, and psychiatric symptoms. Medical conditions associated with 22q11.2DS include congenital heart disease, immune difficulties, and velopharyngeal dysfunction, to name a few. The neurocognitive impairments in individuals with 22q11.2DS include full-scale intelligence quotient (IQ) in the borderline to low-average range 2 with verbal skills generally stronger than nonverbal abilities, although there is significant individual variability. 3 There is a higher prevalence of childhood mental health disorders such as anxiety and attention deficit hyperactivity disorder, 4 and in late adolescence to early adulthood, up to 30% of individuals develop psychotic disorders such as schizophrenia and schizophreniform disorders. 5 While little is known about what early risk factors predict the later development of serious psychiatric illness in 22q11.2DS, one longitudinal study 6 suggests that childhood anxiety disorders and declining verbal IQ precede the emergence of schizophrenia.
According to a recent review, 4 approximately 40% of children with 22q11.2DS experience some type of anxiety disorder, with the prevalence spanning around 4% to 61%. Specific phobias are most common, followed by generalized anxiety disorder, separation anxiety, and obsessivecompulsive disorder. 7 Early negative experience has been shown to increase the risk of anxiety and is associated with atypical development of the physiological stress response. 8 Thus, serious medical complications, such as congenital heart disease, feeding difficulties, and often multiple surgeries or hospitalizations, may also predispose some children with 22q11.2DS to anxiety disorders due to stressors associated with repeated medical procedures or poor sense of control over one's body. 9 In addition to mental health difficulties, individuals with 22q11.2DS face cognitive challenges, with cognitive abilities in the borderline or mild intellectual disability range. Intellectual disability is characterized by belowaverage cognitive functioning and impairments in adaptive behaviors that impact daily living. 10 While IQ scores are often reported as an important outcome measure, IQ tends to represent acquired knowledge and test performance, rather than an individual's real-world daily functioning (i.e., adaptive skills) 11 or the ability to cope with everyday stressors. Adaptive scores are a separate, but related, construct to IQ and are more ecologically valid metrics of development that reflect age-appropriate expectations of one's ability to independently function and communicate in practical and social environments, such as at home, school, in the community, or on the job. 12 Adaptive skills are necessary for becoming an independent, successful adult in society and are often measured by standardized assessments such as the Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) 13 or Adaptive Behavior Assessment System for Children, 2nd edition (ABAS-II). 14 Identifying factors that lead to better adaptive skills are useful targets for intervention to improve an individual's real-world functioning.
The interaction of anxiety and cognitive impairments can negatively affect development by reinforcing maladaptive behaviors. For example, cognitive challenges may be a source of stress and anxiety, leading to avoidance of academic and social situations. Avoidance decreases opportunities for learning, putting children at an even greater disadvantage. In addition, poor interpretation of environmental and social cues secondary to anxiety can also affect daily functioning and limit one's ability to interact and learn from the environment. Furthermore, anxiety can cause physiological changes via cortisol and the stress response, which may have deleterious consequences on both brain and behavior with prolonged exposure. All of these factors may lead to an iterative cycle of events that could exacerbate the already increased risk for psychiatric disorders due to the 22q11.2 deletion. 9 What determines adaptive functioning in children with 22q11.2DS? Our clinical impression working with the school-aged 22q11.2DS population suggests that there is prominent anxiety, and children with more severe anxiety symptoms seem to be the most impaired in their everyday functioning. While there is a robust relationship between IQ and adaptive function in typically developing 13 and other developmentally delayed 15 populations, this has not been investigated specifically in children with 22q11.2DS. Anxiety affects individuals regardless of IQ and may interfere with the relationship between IQ and adaptive functioning in children with 22q11.2DS. The purpose of this study was to empirically test these clinical impressions using standardized assessments. We hypothesized the following:
1. A greater proportion of children with 22q11.2DS
will have elevated anxiety scores compared with typically developing children. 2. In children with 22q11.2DS, those with higher anxiety symptoms will have lower adaptive scores.
In addition, we investigated the domains of anxiety that may affect adaptive scores in more detail, which could be useful for intervention and prevention.
METHODS

Participants
This cross-sectional study included 78 children with chromosome 22q11.2 deletion syndrome (22q11.2DS) (female 5 36 and male 5 42) ages 7 to 15 years (mean age, 10.6 6 2.2 years) who were part of a larger study of neurocognitive function that included neuroimaging. Diagnosis of 22q11.2DS was confirmed with fluorescence in situ hybridization. Recruitment consisted mainly from postings on the Cognitive Analysis and Brain Imaging Laboratory web page or the MIND Institute's Volunteer Research Registry, and participants were not selected from clinical or subspecialty visits related to 22q11.2DS. Instead, almost all families contacted our team asking to participate. The comparison group consisted of 36 (21 girls and 15 boys; mean age, 10.8 6 2.5 years) typically developing (TD), age-matched children from the local geographic area without 22q11.2DS or other known genetic disorders recruited from the MIND Institute's Volunteer Research Registry available online. Inclusion criteria included English speakers and availability of a parent or legal guardian who could provide consent and complete standardized measures of the child's behavior. Any children with contraindication to magnetic resonance imaging (pacemaker, etc) were excluded due to the requirements for participation in the larger study. Exclusion criteria for TD children included presence of any known structural brain abnormalities or birth complications, such as a history of prematurity or multiple births. Socioeconomic status (SES) was measured with the Hollingshead Four Factor Index of Social Status. All procedures were approved by the Institutional Review Board at the University of California at Davis.
Both anxiety measures (Behavior Assessment System for Children, 2nd edition [BASC-2] and Spence Children's Anxiety Scale [SCAS]; see below for description) are based on a mean score of 50 with a 10-point standard deviation. A sample size of 28 children in each group is needed to detect a difference of 3/4 standard deviation (7.5 points) with a power of .8 and a 5 .05 (2 tailed). Sample size was calculated using STATA Version 9.2. 16 (StataCorp LP, College Station, TX).
Measures
Study protocol included neuropsychological testing by a clinical psychologist and a developmental-behavioral pediatric evaluation including history of prior psychiatric diagnoses. Full-scale intelligence quotient (FSIQ) was assessed using the Wechsler Intelligence Scale for Children, 4th edition. 17 Parents completed standardized questionnaires of their child's behaviors and skills. Anxiety symptoms and adaptive skills were measured on 2 levels (1: general and 2: specific).
Analysis 1: General Measures of Anxiety and Adaptive Skills (22q11.2DS vs TD)
The Parent Rating Scales of the BASC-2, 18 a 134 to 160 item questionnaire used to measure children's internalizing and externalizing problems, adaptive skills, and behavioral symptoms, was obtained for all children as part of the protocol for the larger study on neurocognition. This analysis included general measures of anxiety and adaptive skills from the BASC-2, which is normed based on current US census characteristics and includes a "clinical norm sample" of children referred for clinical conditions such as learning disability, developmental delay/intellectual disability, emotional/ behavioral disturbance, attention deficit hyperactivity disorder (ADHD), and other conditions. T scores are normed with an average of 50 and a 10-point standard deviation, so anxiety scores $60 and adaptive skills scores ,40 are considered problematic.
Analysis 2: Specific Measures of Anxiety and Adaptive Skills (22q11.2DS subset)
Anxiety: The BASC-2 does not differentiate between specific anxiety domains, and due to our clinical impression of anxiety having a significant impact on children with the deletion, we started collecting more detailed measures of anxiety (Spence Children's Anxiety Scale [SCAS] ) and adaptive measures (Adaptive Behavior Assessment System, 2nd edition [ABAS-II]), prospectively for a subset of participants with 22q11.2DS, with complete data available for 33 (of the 78) 22q11.2DS children included in Analysis 1. The parent SCAS 19 is a 38-item questionnaire that measures the severity of anxiety symptoms along the dimensions of the DSM-IV diagnostic criteria for anxiety disorders, including panic-agoraphobia, separation anxiety, physical injury, social phobia, obsessive-compulsive disorder, and generalized anxiety disorder. A total anxiety score can also be calculated. Similar to the BASC-2, elevated SCAS subscale t scores are those $60. The SCAS correlates well with the internalizing subscale of the Child Behavior Checklist but has advantages over the Child Behavior Checklist by providing more detailed symptoms of anxiety along DSM-IV classifications and differentiating between children with anxiety disorders and normal controls. 20 Adaptive functioning: The (ABAS-II), 14 a more comprehensive norm-referenced scale of daily living skills, was also collected from this subset. The ABAS-II General Adaptive Composite (GAC) is a standard score with a mean of 100 and a 15-point standard deviation. The GAC scores , 70 are considered "extremely low" and indicate significant functional impairment. Norms based on ratings of more than 3200 individuals in 31 years agegroups are stratified by sex, race/ethnicity, and level of education. In addition to typically developing participants, the standardization sample included 20 clinical groups, representing disorders such as autism, ADHD, and visual impairment. 18 
Statistical Analyses
Two-tailed Student's t tests were used to compare group means for continuous variables, such as age, Full Scale Intelligence Quotient (FSIQ), BASC-2 anxiety, and BASC-2 adaptive skills. In addition, gender ratios and the percentage of children scoring in the elevated range for anxiety (BASC-2) in the 22q11.2DS group were compared with the control group using x 2 analysis. First, the relationship between anxiety and adaptive function was examined for the entire sample (22q11.2DS and TD combined) with multiple linear regression. Adaptive function (as measured by BASC-2 adaptive skills or ABAS-II GAC) was the dependent variable, and anxiety (as measured by BASC-2 anxiety or individual SCAS domains) was the independent variable, with group as a covariate. Linear regression was also used for within group correlational analyses of anxiety and adaptive function and to characterize the relationship between FSIQ and adaptive function (BASC-2 adaptive skills) with gender and SES as covariates. All statistical analyses were calculated using STATA Version 9.2. 16 
RESULTS
There were no significant differences in demographic characteristics such as age, gender, or socioeconomic (SES) between the chromosome 22q11.2 deletion syndrome (22q11.2DS) and TD groups. Mean FSIQ was in the borderline range (76 6 12.9) for the 22q11.2DS group and average range (108.8 6 13) for the TD group (see Table 1 ). Based on the qualitative report from parents, 19% of the 22q11.2DS group had a prior diagnosis of an anxiety disorder from a medical or mental health professional. A far greater percentage (58%; n 5 46) of the children with 22q11.2DS had elevated (t score $60) Behavior Assessment System for Children, 2nd edition (BASC-2) or Spence Children's Anxiety Scale (SCAS) anxiety scores. FSIQ, BASC-2 anxiety, and BASC-2 adaptive skills were available for all 78 children with 22q11.2DS and 36 TD children in Study 1. For study 2, both (parent) SCAS and ABAS-II scores were available for 33 (of 78) children with 22q11.2DS. There were no significant differences between the larger 22q11.2DS group (n 5 78) and smaller subgroup for which SCAS scores (n 5 34) were available, with similar age (10.
) (p 5 .003). BASC-2 anxiety scores were in the average range for both groups, although a significantly greater portion of children with 22q11.2DS (29 of 78; 37%) had elevated ($60) BASC-2 anxiety scores compared to TD children (5 of 36; 14%; p 5 .01). These prevalence rates are similar to those reported in the literature for both the 22q11.2DS (approximately 40%) 4 and the general population (approximately 10%). 21 Mean BASC-2 adaptive skill scores were significantly higher in TD children (54 6 8.3) compared to those with 22q11.2DS (39.2 6 9.8; p , .001), with higher adaptive scores indicating better functioning. Forty-two children (54%) with 22q11.2DS had low (BASC-2 adaptive skills ,40) adaptive scores, whereas only 2 TD children (6%) were in this range (p , .001).
When the entire sample (i.e., both the 22q11.2DS and TD groups combined) was tested, higher anxiety scores were related to lower adaptive function (r 5 2.42; p , .001). A multiple regression model (i.e., 22q11.2DS, TD) with group and BASC-2 anxiety as covariates predicted BASC-2 adaptive skills (adjusted R 2 5 .4; p , .001). Both group (t 5 26.76; p , .001) and BASC-2 anxiety (t 5 23.38; p , .001) were statistically significant predictors of adaptive function, so we then performed within group analysis to see if the relationship between BASC-2 adaptive skills and anxiety differed by group.
Within group analysis revealed a negative relationship between anxiety and adaptive function in both TD (r 5 2.42; p 5 .01) and 22q11.2DS (r 5 2.27; p 5 .015) children using the BASC-2. As we hypothesized, higher anxiety scores were related to lower adaptive function in children with 22q11.2DS (Fig. 1) . This finding remained significant after adjusting for FSIQ, gender, and SES (r 5 2.26; p 5 .019). There was no relationship between Wechsler Intelligence Scale for Children, 4th edition (WISC-IV) FSIQ and BASC-2 adaptive skills (Fig. 2) in children with 22q11.2DS, either with (r 5 2.08; p 5 .5) or without (r 5 2.06, p 5 .6) adjusting for the above covariates. By contrast, TD children in our study showed a strong positive correlation between FSIQ and adaptive function (unadjusted r 5 .5; p 5 .003 and adjusted r 5 .6; p 5 .002) (Fig. 2, right panel) . There was no relationship between BASC-2 anxiety and FSIQ in the 22q11.2DS group (r 5 .06; p 5 .62) (Fig 2, left 
DISCUSSION
Based on our study of children ages 7 to 14 years with chromosome 22q11.2 deletion syndrome (22q11.2DS), anxiety symptoms are quite common and negatively related to adaptive functioning. This has serious clinical implications because, from our sample, anxiety appears to be underidentified by health care professionals, despite known elevated risk in this population. 4, 22 Only 19% of our participants had been given a prior diagnosis of an anxiety disorder, yet 58% of them demonstrated elevated Behavior Assessment System for Children, 2nd edition (BASC-2) or Spence Children's Anxiety Scale (SCAS) scores, representing significant anxiety symptoms. Certain subtypes of anxiety were more frequent than others, with fear-based symptoms (i.e., separation anxiety and fear of physical injury) present in approximately 60% of children, compared to a 20% rate of obsessive-compulsive or panic-agoraphobia symptoms. This discrepancy may provide insight for future study of the physiological mechanisms involved in these types of anxiety, along with targeted interventions. Our initial study protocol addressed a global measure of anxiety from the BASC-2, with approximately 38% of children with 22q11.2DS scoring in the elevated range. While this was consistent with the prevalence of anxiety disorders reported in the literature for this population, 4 this also seemed to underestimate the actual rate given our clinical impression of frequent anxiety symptoms causing significant impairment and was our motivation for our secondary analysis using the SCAS. The mean BASC-2 anxiety score in the 22q11.2DS group was in the average range, although it was significantly higher than the mean BASC-2 anxiety score in the typically developing (TD) group by 7 points. This may be related to the heavy loading of questions in the BASC-2 relating to generalized anxiety (mostly worries), which, on the SCAS, was present on only approximately 40% of children, and the inability of some children with 22q11.2DS to explicitly express or communicate anxiety symptoms due to verbal and intellectual impairments. Inadequate treatment of identified mental health conditions in children with 22q11.2DS has also been reported, 22 and together with our findings that anxiety symptoms are common and often unidentified, there is a demonstrated need to address this pervasive problem as a prime target for intervention.
We started collecting more detailed information on DSM-IV-related anxiety subtypes using the SCAS to evaluate our hypothesis that the general nature of the BASC-2 was underestimating the prevalence of anxiety in children with 22q11.2DS. While mean scores on the different anxiety measures were mostly in the average range, there was a wide spread of scores, with at least 18% of the children with 22q11.2DS having elevated t scores on any anxiety subscale and up to 60% with elevations for certain anxiety subtypes such as separation anxiety. Importantly, it was these children who had the greatest difficulty with everyday living skills, which highlights the need to treat anxiety in this population. The same pattern held also for the general measures from the BASC-2.
Specific subtypes of anxiety may predict lower adaptive functioning, including panic-agoraphobia, physical injury, and obsessive-compulsive disorder. Separation anxiety, social phobia, and generalized anxiety disorder, while present in more than 40% of our sample, do not seem to affect adaptive functioning and further study of what types of anxiety symptoms influence this outcome should be pursued.
Anxiety symptoms are common in other neurogenetic disorders, such as Down syndrome, 23 fragile X syndrome, 24 and the sex chromosome aneuploidies such as XXY 25 and trisomy X. 26 Few studies have looked at the relationship between anxiety and adaptive function. In typical populations 27, high anxiety relates to lower intelligence quotients (IQ), but this is not the case in some developmental disorders such as autism, where higher anxiety is found in those with high IQ. 28 Our findings indicate that in 22q11.2DS, anxiety may affect individuals across all levels of cognition, thereby suggesting other modulatory factors such as environmental demands. This may have broader applicability to other neurodevelopmental disorders, and there is a need for further study of the relationship between anxiety and IQ across disorders.
Our findings highlight the importance of identifying and treating anxiety symptoms in children with 22q11.2DS. While intellectual potential is certainly an important outcome measure, there are other factors that influence long-term function. Anxiety interferes with the deployment of one's cognitive potential to attain maximal adaptive functional skills, as evidenced by the lack of relationship between IQ and adaptive functioning in our 22q11.2DS sample. In our control group of TD children who had a low prevalence of anxiety, higher IQ scores were related to better adaptive functioning, consistent with what is reported in the literature for typical and many developmentally delayed populations. We postulate that this lack of correlation between IQ and adaptive functioning is related to anxiety because anxiety may potentially alter one's interaction with the environment through the modulation of attention and fear conditioning [29] [30] [31] so that anxious children miss out on learning opportunities because relatively benign situations are perceived as threatening. Another possibility is that anxious children are less aware or engaged during routine learning environments because there is competition for their attentional resources that are instead focused on perceived threat. Interventions, both behavioral and pharmacologic, to reduce anxiety are available and may improve adaptive functioning and quality of life in the immediate future. Additionally, evidenced-based interventions targeting anxiety are more readily available than interventions geared toward improving cognition. Behavioral techniques that teach useful coping skills and encourage positive environmental interactions allow one to better perform to the maximum of his or her cognitive potential to encourage independent functioning and improve relationships.
It is also possible that early anxiety reduction and the attainment of coping skills could protect against the development of serious psychopathology later in life, which is particularly relevant to the 22q11.2DS population given these individuals' elevated risk for schizophrenia. In our analysis, the obsessive-compulsive and panic-agoraphobia subscales of the SCAS were more strongly related to adaptive function. In the general population, there is an increased risk of schizophrenia in individuals previously diagnosed with an anxiety disorder, 32 and anxiety disorders and schizophrenia are often comorbid. 33 In schizophrenia, anxiety affects quality of life and may mediate social and functional impairment. 33 The only longitudinal study of which we are aware that examined this relationship in children with 22q11.2DS indicated that those with any anxiety, but particularly obsessive-compulsive disorder, appeared to be at higher risk for schizophrenia at follow-up after 5 years. 6 Mental health screening is particularly important in order to identify difficulties early and provide treatment.
In the context of early negative life events, ongoing cognitive and socioemotional challenges and a genetic diathesis, the contribution of stress from poor coping skills and high levels of anxiety may account for some of the elevated risk of schizophrenia in adolescents and young adults with 22q11.2DS. 9 Chronic anxiety and panic symptoms may contribute to poor developmental outcomes through prolonged activation of the physiological stress response, including chronically elevated glucocorticoid and catecholamine activation. Chronic glucocorticoid activation has been shown to have deleterious effects on a number of brain regions (including the prefrontal cortex and limbic regions) that could contribute to and also exacerbate emotional dysregulation in a reciprocal and iterative fashion. 34 As a result of these findings, we have begun to refer to children with high anxiety and low adaptive functioning scores as "strugglers" and those with the opposite pattern as "copers." Since, in our sample, coper/struggler status is unrelated to intellectual functioning levels and may modulate risk or resilience with respect to psychiatric illness, 9 we are starting to investigate the factors that contribute to being a "coper" or a "struggler" and how to intervene to convert the latter into the former with evidence-based therapies such as cognitive behavioral therapies and/or or selective serotonin reuptake inhibitor medication and with newer emerging researchbased strategies. 35 Limitations of our study include a smaller sample size (n 5 34) with more specific measures of anxiety from the SCAS, although our sample size of 78 for general measures (BASC-2) is greater than most of the studies on anxiety in 22q11.2DS population in the literature, with subject numbers mostly in 20s. 7, 36, 37 Based on our power analysis calculations, our study may have been slightly underpowered to detect smaller differences in anxiety scores between the groups, which would tend to underestimate our findings. However, given our significant results, our findings seem quite robust. Given the low rate of general anxiety on the BASC-2, we did not collect more detailed anxiety measures for the TD group, which is another limitation. While we employed the use of standardized behavioral measures such as the BASC-2, SCAS, and Adaptive Behavior Assessment System, 2nd edition, these tools rely on parental report and may not truly represent the child's internalizing symptoms. Child self-report scales are available, although we chose the parental scales due to the younger age of our population complicated by developmental/intellectual delay, which limits the validity of self-report because of conceptual, linguistic, and social limitations. 38, 39 In addition, there may be selection bias of families with children experiencing behavioral problems or academic difficulties being more likely to participate in our study because they are seeking help for these conditions, although it is surprising that very few had sought out care through their own medical or mental health care system. However, Young et al 22 also noted that children in their sample with 22q11.2DS and psychopathology were not receiving needed mental health services, and our finding of the dissociation between FSIQ and adaptive function highlight the importance of intervention. One last limitation is the subjective nature of anxiety symptoms, and we did not collect physiological measures of arousal.
Strengths of our study include the inclusion of a TD control group and relatively large sample size. Data on adaptive function and anxiety were collected from children participating in a larger study of neurocognition in 22q11.2DS, and participants were not recruited from a psychiatry clinic or study specifically focused on anxiety or behavior problems, which decreases ascertainment bias. We add to the literature by relating anxiety symptoms to adaptive functioning, which may be a more pragmatic outcome measure than IQ alone. Our findings suggest that treatment of anxiety symptoms may influence adaptive function and support independent life skills. This is important considering that interventions to decrease anxiety are more readily available than treatments focused on improving IQ.
In summary, anxiety symptoms are prevalent in children with 22q11.2DS and interfere with adaptive functioning. The often-observed relationship between IQ and adaptive functioning is not observed in children with 22q11.2DS, perhaps because of their significant anxiety symptoms. Validation of our findings that panic-agoraphobia and obsessive-compulsive disorder more significantly impact the daily functioning will be useful for future studies to help identify prognostic factors and implement targeted therapies.
